Does smoking cessation with varenicline worsen vascular endothelial function? - Wikidata - wikimedia - TriplyDB

Does smoking cessation with varenicline worsen vascular endothelial function?

Does smoking cessation with varenicline worsen vascular endothelial function?

http://www.wikidata.org/entity/Q36956697

about

Smoking cessation in Asians: focus on varenicline Impact of incarceration experiences on reported HIV status and associated risk behaviours and disease comorbidities.Is microplegia really superior to standard blood cardioplegia? The results from a meta-analysis.

P2860

Q35491463-F281EC67-55EF-4659-A0E8-20373D1AE18A Q36853512-5B46FA08-D09F-46D6-81B9-851A89CE1D35 Q38206391-884D0531-A98C-4C9D-9A4E-5111828A5C96

P2860

Does smoking cessation with varenicline worsen vascular endothelial function?

http://www.wikidata.org/entity/Q36956697

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Does smoking cessation with varenicline worsen vascular endothelial function?

@en

type

label

Does smoking cessation with varenicline worsen vascular endothelial function?

@en

prefLabel

Does smoking cessation with varenicline worsen vascular endothelial function?

@en

P1433

Q36956697-106A0032-5BC8-4F8A-B4CA-5FB7C670E67F

P1476

Q36956697-F4126C5A-B243-440B-AB26-5355D10DC496

P2093

Q36956697-0DDE5296-B549-4DA7-ACF2-402AA55A1DAD

Q36956697-2E34A89E-5A67-4BA7-A6B7-4DF9880457D4

Q36956697-5087380E-1A82-4B95-A51D-0F12EE7F6052

Q36956697-549EC26D-50B2-41EC-93C2-858E65E015AF

Q36956697-7597A2EB-308D-4E75-8C44-2C0DD12DA290

Q36956697-82791468-1B0B-4BBB-8936-C31C4E6E46D3

Q36956697-97F819AC-6EB9-40F9-9B88-07CF46109AF1

Q36956697-B1FDE201-7255-450C-BE8C-A2B5213FDB24

P2860

Q36956697-097F5099-F431-4D56-9E59-A8ABE70281CB

Q36956697-1AE68E92-B064-4C78-AD4E-D31A7C0177F7

Q36956697-2763BB4F-9251-4C99-BD9D-A7FCEDE01525

Q36956697-378B8403-A53D-4773-910B-F7317D71C36A

Q36956697-39F56624-D5BC-45DB-A1CB-68086C253941

Q36956697-509B9298-E5D8-4E9A-AB97-9979093945A6

Q36956697-5EB55801-5770-465F-AF55-AA294C975522

Q36956697-6EDA39AD-10E4-43FB-87AF-9D89EAA8B295

Q36956697-753E6100-AC82-42C4-821C-9AA5D6732A62

Q36956697-951F5ACE-FBC0-41E8-8222-DECA71E8A35E

P31

Q36956697-F4328C0A-F352-4EB2-B104-0F1C6C560F46

P356

Q36956697-F00994B4-8B72-4A03-ABD1-BF0D88A022FA

P433

Q36956697-DBCB46FD-ED80-4230-9FCB-1C3B274E1F22

P478

Q36956697-0BDB6E4B-6B5F-40C2-9F2C-8BEBB906E2BE

P577

Q36956697-1505F411-C112-40F0-A7E9-6156FA671B21

P5875

Q36956697-FCE76932-6269-4AA6-9832-61B2C1B58AB7

P698

Q36956697-C509920B-E8F5-4960-8A6B-919D070F11A1

P921

Q36956697-9FFF4558-5854-4FDB-BC5B-F995CE9044A4

P932

Q36956697-335D5250-4DC1-496F-A544-09337EABE8FD

P356

BMJOPEN-2013-003052

P1433

P1476

Does smoking cessation with varenicline worsen vascular endothelial function?

@en

P2093

Akira Umeda

http://www.w3.org/2001/XMLSchema#string

Heiichi Yano

http://www.w3.org/2001/XMLSchema#string

Hiroshi Takeda

http://www.w3.org/2001/XMLSchema#string

Kazuya Miyagawa

http://www.w3.org/2001/XMLSchema#string

Tamio Ieiri

http://www.w3.org/2001/XMLSchema#string

Tateki Yamane

http://www.w3.org/2001/XMLSchema#string

Toru Kato

http://www.w3.org/2001/XMLSchema#string

Yasumasa Okada

http://www.w3.org/2001/XMLSchema#string

P2860

Risk of serious adverse cardiovascular events associated with varenicline: a systematic review and meta-analysis

Risk of cardiovascular serious adverse events associated with varenicline use for tobacco cessation: systematic review and meta-analysis

Efficacy and safety of varenicline for smoking cessation in patients with cardiovascular disease: a randomized trial

Effects of smoking and smoking cessation on endothelial function: 1-year outcomes from a randomized clinical trial.

Role of endothelial dysfunction in atherosclerosis.

Weight gain in smokers after quitting cigarettes: meta-analysis.

Interventions to increase smoking cessation at the population level: how much progress has been made in the last two decades?

An algorithm for tailoring pharmacotherapy for smoking cessation: results from a Delphi panel of international experts.

Flow-mediated vasodilation as a diagnostic modality for vascular failure.

Varenicline: a pharmacoeconomic review of its use as an aid to smoking cessation.

P31

scholarly article

P356

10.1136/BMJOPEN-2013-003052

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

3

http://www.w3.org/2001/XMLSchema#string

P577

2013-06-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

241694782

http://www.w3.org/2001/XMLSchema#string

P698

23794597

http://www.w3.org/2001/XMLSchema#string

P921

P932

3693419

http://www.w3.org/2001/XMLSchema#string